Notice for vosoritide (BioMarin Pharmaceutical Australia Pty Ltd)
Active ingredients
vosoritide
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection
Indication
Treatment of achondroplasia in patients less than 2 years of age
Therapeutic area
Inherited bone disorder